BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 16
• 17
• 18
• 19
• 20
• 23
• 24
• 25
• 26
• 27
• 29
• 30
• 31

• Press Releases

  New and updated data for Roche’s fixed-duration Columvi and Lunsumio at ASH 2024 reinforce their potential to improve outcomes for people with lymphoma

  December 10, 2024

   · 

  12 min read
• Press Releases

  Santhera Receives Positive Recommendation from NICE for AGAMREE® (Vamorolone) as a Treatment for Duchenne Muscular Dystrophy

  December 10, 2024

   · 

  6 min read
• Press Releases

  Relation announces two strategic collaborations with GSK to advance therapeutics for fibrotic diseases and osteoarthritis

  December 10, 2024

   · 

  2 min read
• Press Releases

  CARVYKTI®▼ (ciltacabtagene autoleucel; cilta-cel) demonstrated significantly higher rates of minimal residual disease negativity compared to standard therapies in the CARTITUDE-4 study

  December 10, 2024

   · 

  13 min read
• Press Releases

  Wyss Center for Bio and Neuroengineering Announces Venture with dEEGtal Insight: An Innovative Tool for Early Epilepsy Detection

  December 10, 2024

   · 

  2 min read
• Press Releases

  IN8bio Reports Continued Progression-Free Survival in Phase 1 Investigator-Sponsored Trial of INB-100 Allogeneic Gamma-Delta T Cells for Leukemias at the 2024 American Society of Hematology Annual Meeting

  December 10, 2024

   · 

  8 min read
• Press Releases

  Microbix Assisting EMQN with Novel Genetic-Test EQA Program

  December 10, 2024

   · 

  5 min read
• Press Releases

  CervoMed Announces Topline Data from RewinD-LB Phase 2b Clinical Trial in Patients with Dementia with Lewy Bodies

  December 10, 2024

   · 

  8 min read
• Press Releases

  Scilex Holding Company Enters into a Binding Term Sheet for a Joint Venture with IPMC and Bio Open Innovation Consortium to Develop and Commercialize a Phase 2 Clinical Stage, Potential Best-In-Class Novel Oral Tablet for the Treatment of Obesity and Neurodegenerative Diseases Including Alzheimer’s Disease

  December 10, 2024

   · 

  11 min read
• Press Releases

  NewBiologix Launches U.S. Subsidiary and Welcomes Gene and Cell Therapy Expert David Kelly as Business Development Manager

  December 10, 2024

   · 

  3 min read